What does CUSIP 45408X308 represent in this 13F holders report?

CUSIP 45408X308 is the security identifier for IGC - IGC Pharma, Inc. - COM NEW used to aggregate holder disclosures.

How many institutions held IGC - IGC Pharma, Inc. - COM NEW in Q2 2021?

26 institutional investors reported IGC - IGC Pharma, Inc. - COM NEW for Q2 2021. Use the holders table for investor-level position and value details.

IGC Pharma, Inc. - COM NEW (IGC)

CUSIP: 45408X308

Q2 2021 13F Holders as of 30 Jun 2021

Type / Class: Equity / COM NEW
Total 13F shares: 4,807,060
Share change: +372,444
Total reported value: $7,893,000
Put/Call ratio: 47%
Price per share: $1.64
Number of holders: 26
Value change: +$553,068
Number of buys: 11
Number of sells: 11

Quarterly Holders Quick Answers

What is CUSIP 45408X308?
CUSIP 45408X308 identifies IGC - IGC Pharma, Inc. - COM NEW in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Next holder-history checks

These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.

Back to full security ownership history for the broader multi-quarter picture.
Latest 13F filings for newly reported positions across managers.
Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
SEC investors directory for manager drilldown.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q3 2021
Previous quarter: Q1 2021

Recent filing periods for CUSIP 45408X308:

Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024

Top shareholders of IGC - IGC Pharma, Inc. - COM NEW (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
BlackRock Finance, Inc.	13F	Company	— class O/S missing	910,966	$1,631,000	—	31 Mar 2021	13F
IQ EQ FUND MANAGEMENT (IRELAND) Ltd	13F	Company	— class O/S missing	835,363	$1,495,000	—	31 Mar 2021	13F
VANGUARD GROUP INC	13F	Company	— class O/S missing	714,372	$1,279,000	—	31 Mar 2021	13F
SUSQUEHANNA INTERNATIONAL GROUP, LLP	13F	Company	— class O/S missing	490,356	$878,000	—	31 Mar 2021	13F
Carroll Financial Associates, Inc.	13F	Company	— class O/S missing	320,000	$572,000	—	31 Mar 2021	13F
GEODE CAPITAL MANAGEMENT, LLC	13F	Company	— class O/S missing	261,671	$468,000	—	31 Mar 2021	13F
BRIDGEWAY CAPITAL MANAGEMENT, LLC	13F	Company	— class O/S missing	248,700	$445,000	—	31 Mar 2021	13F
Vontobel Holding Ltd.	13F	Company	— class O/S missing	120,000	$212,000	—	31 Mar 2021	13F
DEARBORN PARTNERS LLC	13F	Company	— class O/S missing	96,901	$173,000	—	31 Mar 2021	13F
SIMPLEX TRADING, LLC	13F	Company	— class O/S missing	86,816	$155,000	—	31 Mar 2021	13F
GOLDMAN SACHS GROUP INC	13F	Company	— class O/S missing	83,260	$149,000	—	31 Mar 2021	13F
NORTHERN TRUST CORP	13F	Company	— class O/S missing	63,328	$113,000	—	31 Mar 2021	13F
GROUP ONE TRADING LLC	13F	Company	— class O/S missing	55,351	$99,000	—	31 Mar 2021	13F
Rohit Goel	3/4/5	Senior Director of Finance&PAO	— class O/S missing	235,000	$79,900	—	13 May 2021	3/4/5
PRICE T ROWE ASSOCIATES INC /MD/	13F	Company	— class O/S missing	43,000	$77,000	—	31 Mar 2021	13F
TRUIST FINANCIAL CORP	13F	Company	— class O/S missing	41,593	$75,000	—	31 Mar 2021	13F
Engineers Gate Manager LP	13F	Company	— class O/S missing	22,800	$41,000	—	31 Mar 2021	13F
CITADEL ADVISORS LLC	13F	Company	— class O/S missing	15,381	$28,000	—	31 Mar 2021	13F
OSAIC HOLDINGS, INC.	13F	Company	— class O/S missing	13,748	$25,000	—	31 Mar 2021	13F
BANK OF AMERICA CORP /DE/	13F	Company	— class O/S missing	11,148	$20,000	—	31 Mar 2021	13F
Cutler Group LLC / CA	13F	Company	— class O/S missing	10,357	$18,000	—	31 Mar 2021	13F
Geneos Wealth Management Inc.	13F	Company	— class O/S missing	3,200	$5,000	—	31 Mar 2021	13F
UBS Group AG	13F	Company	— class O/S missing	1,391	$3,000	—	31 Mar 2021	13F
BARCLAYS PLC	13F	Company	— class O/S missing	537	$1,000	—	31 Mar 2021	13F
MORGAN STANLEY	13F	Company	— class O/S missing	500	$1,000	—	31 Mar 2021	13F
Better Money Decisions, LLC	13F	Company	— class O/S missing	425	$1,000	—	31 Mar 2021	13F
Abundance Wealth Counselors	13F	Company	— class O/S missing	400	$1,000	—	31 Mar 2021	13F
Capital Analysts, LLC	13F	Company	— class O/S missing	307	$1,000	—	31 Mar 2021	13F

Institutional Holders of IGC Pharma, Inc. - COM NEW (IGC) as of Q2 2021

As of 30 Jun 2021, IGC Pharma, Inc. - COM NEW (IGC) was held by 26 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 4,807,060 shares. The largest 10 holders included Davy Global Fund Management Ltd, BlackRock Inc., VANGUARD GROUP INC, SUSQUEHANNA INTERNATIONAL GROUP, LLP, RENAISSANCE TECHNOLOGIES LLC, GEODE CAPITAL MANAGEMENT, LLC, STATE STREET CORP, BRIDGEWAY CAPITAL MANAGEMENT, LLC, Virtu Financial LLC, and DEARBORN PARTNERS LLC. This page lists 26 institutional shareholders reporting positions in this security for the Q2 2021 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q2 2021 vs Q1 2021 Across Filers

Q1 2021 holders

Q2 2021 holders

Holder diff

Investor	Q1 2021 Shares	Q2 2021 Shares	Share Diff	Share Chg %	Q1 2021 Value $	Q2 2021 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.